Medinet (2370) · RiskMaterialised
Delayed Patient Enrollment Due to Adverse Events in the Phase IIb Trial for Chronic Heart Failure
First written in FY2024-Q1. 1 of 1 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2024-Q1.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Uncertainty over Prolonged or Discontinued Drug Development Pipelines and CommercializationA theme 70 companies write about · 86 as a headwind · 0 as a tailwind
Medinet moved to the "Worse" side of this theme in 2024, 4 years after the typical company in this theme (2020).
The whole theme swung hardest in 2022: 20 of 41 companies on the "Worse" side.
22 other companies' latest entry also says "Materialised".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 70 companies compared. The sentences above are computed from all 70.Full recordFilings, disclosures and news, newest first